These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3716728)

  • 21. [Initial antithrombotic therapy for pulmonary embolism].
    Bertoletti L; Mismetti P
    Rev Mal Respir; 2011 Feb; 28(2):216-26. PubMed ID: 21402235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Massive pulmonary thromboembolism: medical or surgical treatment?].
    Colombi P; Merli M; Zogno M; Pellegrini A
    G Ital Cardiol; 1979; 9(9):984-6. PubMed ID: 520747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible gender-related differences in the risk-to-benefit ratio of thrombolysis for acute submassive pulmonary embolism.
    Geibel A; Olschewski M; Zehender M; Wilsch M; Odening K; Heinrich F; Kasper W; Konstantinides S
    Am J Cardiol; 2007 Jan; 99(1):103-7. PubMed ID: 17196471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescription of heparin in the acute phase of myocardial infarction: expected and observed benefits...].
    Cador R; Weber S
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1479-84. PubMed ID: 9092406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"].
    Couturaud F
    Rev Pneumol Clin; 2008 Dec; 64(6):332-6. PubMed ID: 19084215
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
    Spitzer W; Durst OE; Lang E
    Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic approach to pulmonary embolism].
    Phlippoteau C; Girard P; Musset D; Bridey F; Millat B; Petitpretz P; Simonneau G; Duroux P
    J Mal Vasc; 1989; 14(3):213-5. PubMed ID: 2778395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombotic therapy for ischemic cerebrovascular accident].
    Mas JL
    Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():53-7. PubMed ID: 12500606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anticoagulants in prevention and treatment of pulmonary thromboembolic diseases].
    Gherasim L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):335-41. PubMed ID: 14369
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticoagulant and thrombolytic drugs. II. Clinical aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(4):303-19. PubMed ID: 4939607
    [No Abstract]   [Full Text] [Related]  

  • 34. [Patients with lung emboli and hemodynamic stability: insufficient evidence for routine thrombolysis].
    Huisman MV
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1373-5. PubMed ID: 15997688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
    Gross R
    Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
    [No Abstract]   [Full Text] [Related]  

  • 36. Anticoagulant therapy, antithrombotic therapy, pulmonary embolism, and the Henry Ford Hospital perspective.
    Stein PD
    Henry Ford Hosp Med J; 1988; 36(1):28. PubMed ID: 3397293
    [No Abstract]   [Full Text] [Related]  

  • 37. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient treatment of pulmonary embolism with dalteparin.
    Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
    Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulmonary embolism: incidence, diagnosis, prevention, and treatment.
    Garmon RG
    J Am Osteopath Assoc; 1985 Mar; 85(3):176-85. PubMed ID: 3980263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.